Trial intelligence / Profile preview

Safety of INDIRAB Rabies Vaccine in Healthy Vietnamese Volunteers

NCT02729168Completed

Start
Oct 2015
Primary completion
Oct 2015
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label, single-arm trial of rabies vaccine in rabies. Primary endpoints: Adverse Events at 7 days and Serious Adverse Events at 35 days. Started Oct 2015; status: completed.

02

Drugs

rabies vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on NCT02729168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02729168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call